SCHEMBL23027375

SCHEMBL23027375

COc1ccc(F)cc1CC=C(C)C

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 7/20 0.47
ALOX5 P09917 3/20 0.47
PTGES O14684 1/20 0.47
NFKB1 P19838 1/20 0.47
STAT3 P40763 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
PTPN1 P18031 6/20 0.46
AKR1C3 P42330 3/20 0.46
AKR1C2 P52895 3/20 0.46
ABCB1 P08183 1/20 0.44
ALDH1A1 P00352 2/20 0.43
GAA P10253 1/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
PTGS2 P35354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18123531 0.83 CYP19A1 (0.47) CYP19A1ALOX5PTGESNFKB1STAT3
SCHEMBL17626921 0.80 IDO1 (0.48) CYP19A1ALOX5PTGESNFKB1STAT3
SCHEMBL3303362 0.79 CYP19A1 (0.56) CYP19A1ALOX5PTGESNFKB1STAT3
SCHEMBL16710352 0.79 CYP19A1 (0.53) CYP19A1ALOX5PTGESNFKB1STAT3
SCHEMBL30536248 0.79 ALDH1A1 (0.52) ALDH1A1GAAMEN1POLBHPGD
SCHEMBL21358033 0.79 GABRA1 (0.56) ALOX5PTPN1ALDH1A1MEN1POLB
SCHEMBL23027377 0.79 HTT (0.60) CYP19A1PTPN1AKR1C3ALDH1A1GAA
SCHEMBL2689127 0.79 ALDH1A1 (0.52) ALDH1A1GAAMEN1POLBHPGD
SCHEMBL2691262 0.77 KMT2A (0.40) AKR1C3AKR1C2ALDH1A1GAAMEN1
SCHEMBL24805134 0.77 HTT (0.50) CYP19A1PTPN1AKR1C3ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021032074-A1 BENZAMIDE FUSED AROMATIC RING DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE 江苏恒瑞医药股份有限公司 2021-02-25 WO disclosed